QPRN funding

The Network is funded by a unique public-private partnership between:

the Fonds de recherche du Québec – Santé (FRQS), the Ministère de la santé et des services sociaux du Québec (MSSS), Pfizer Canada, and Astrazeneca.

The partnership – a first in Canada when it was announced in 2008 – was designed to:

  • Financially support the Pain Network
  • Stimulate cutting edge research on chronic pain
  • Perfect the public and health care professional’s education on chronic pain
  • Improve our background knowledge on chronic pain
  • Contribute to enhancing physicians judgement for diagnosing and treating chronic pain

If you want to know more, read the press release here: